Solicitation of Nominations for Appointment to the Advisory Board on Radiation and Worker Health for the Energy Employees Occupational Illness Compensation Program Act of 2000, 35291-35292 [2021-14204]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
A. Federal Reserve Bank of Atlanta
(Erien O. Terry, Assistant Vice
President) 1000 Peachtree Street NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. The Sue Soileau Trust, Steven G.
Durio and Anthony Kip Bertrand, as cotrustees, The David C. Brignac, Jr. Trust,
Steven G. Durio, as trustee, all of
Lafayette, Louisiana; and the
Washington State Bancshares Employee
Stock Ownership Plan (ESOP),
Washington Louisiana, Steven G. Durio,
as trustee of the ESOP, as a group acting
in concert to acquire additional voting
shares of Washington State Bancshares,
Inc. and thereby indirectly acquire
additional voting shares of Washington
State Bank, both of Washington,
Louisiana.
Board of Governors of the Federal Reserve
System, June 28, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–14153 Filed 7–1–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Board on
Radiation and Worker Health for the
Energy Employees Occupational
Illness Compensation Program Act of
2000
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
Advisory Board on Radiation and
Worker Health (ABRWH) for the Energy
Employees Occupational Illness
Compensation Program Act of 2000
(EEOICPA). The ABRWH consists of not
more than 20 members appointed by the
President of the United States, and shall
reflect a balance of scientific, medical,
and worker perspectives. Nominations
are being sought for individuals who
have expertise and qualifications
necessary to contribute to the
accomplishments of the ABRWH’s
objectives. Nominees will be appointed
based on their demonstrated
qualifications, professional experience,
and knowledge of issues the ABRWH
may be asked to consider. Federal
employees will not be considered for
membership.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
Nominations for individuals to
serve on the ABRWH must be submitted
(postmarked, if sending by mail;
submitted electronically; or received, if
hand delivered) no later than August 2,
2021. Packages received after this time
will not be considered.
ADDRESSES: Nominations may be
submitted, including attachments, by
any of the following methods below:
• Electronically: Email:
(recommended) to Nancy Adams, dcas@
cdc.gov (specify in the email subject
line, ‘‘Advisory Board on Radiation and
Worker Health Nomination’’); or
• Mail: Express Delivery, hand
delivery messenger, or courier service:
Submit one copy of all required
documents to the following address:
Nancy Adams, ABRWH, Office of the
Director, National Institute of
Occupational Safety and Health, Centers
for Disease Control and Prevention, 395
E Street SW, Suite 9200, Patriots Plaza,
Washington, DC 20201.
Follow-up communications with
nominees may occur as necessary
throughout the process.
FOR FURTHER INFORMATION CONTACT:
Nancy Adams, National Institute for
Occupational Safety and Health
(NIOSH); Telephone: (540) 431–8024;
Email: dcas@cdc.gov (Specify in the
email subject line, ‘‘Advisory Board on
Radiation and Worker Health
Nomination’’).
SUPPLEMENTARY INFORMATION: The
Centers for Disease Control and
Prevention (CDC) invites interested
parties to submit nominations for
individuals to serve on the ABRWH for
the Energy Employees Occupational
Illness Compensation Program Act of
2000. The ABRWH was established
pursuant to Section 3624 of Public Law
106–398, and Section 4 of Executive
Order 13179, ‘‘Providing Compensation
to America’s Nuclear Weapons
Workers,’’ dated December 7, 2000. The
ABRWH is governed by the provisions
of the Federal Advisory Committee Act,
Public Law 92–463, as amended (5
U.S.C. app. 2), which sets forth
standards for the formation and use of
advisory committees. The statutory
authority for the ABRWH is codified at
42 U.S.C. 7384o. The ABRWH currently
operates under Executive Order 13889,
dated September 27, 2019.
Section 4(b) of Executive Order 13179
establishes that the ABRWH shall
provide advice to the Secretary, HHS on
(1) the development of guidelines to
assess the likelihood that an individual
with cancer sustained the cancer in the
performance of duty at a Department of
Energy (DOE) or an Atomic Weapons
Employer (AWE) facility, and methods
DATES:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
35291
for arriving at and providing reasonable
estimates of the radiation doses received
by individuals applying for assistance
under this program for whom there are
inadequate records of radiation
exposure; (2) the scientific validity and
quality of dose reconstruction efforts
performed for purposes of the
compensation program; and (3) upon
request by the Secretary, HHS, whether
there is a class of employees at any DOE
or AWE facility who were exposed to
radiation but for whom it is not feasible
to estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation dose may have
endangered the health of members of
the class. More information on the
ABRWH is available at https://
www.cdc.gov/niosh/ocas/ocasadv.html.
As required by 42 U.S.C. 7384o(a)(2),
the President shall make appointments
to the Board in consultation with
organizations with expertise on worker
health issues in order to ensure that the
membership of the Board reflects a
balance of scientific, medical, and
worker perspectives. The U.S.
Department of Health and Human
Services (HHS) policy stipulates that
committee membership shall be made
without discrimination on the basis of
race, color, sex, religion, ethnicity, age,
disability, gender, sexual orientation,
gender identity, HIV status, genetic
information, cultural, religious, or
socioeconomic status. Minorities,
women, and people with disability are
encouraged to submit their nomination.
Nominees must be U.S. citizens, and
cannot be full-time employees of the
U.S. government. Current participation
on Federal workgroups or prior
experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. ABRWH
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports, and they
serve with compensation and may
receive reimbursement for travel
expenses for their attendance at
ABRWH meetings, including per diem
in lieu of subsistence, as authorized by
the Federal travel regulations. The
activities of the ABRWH may
necessitate its members to obtain a topsecret security clearance.
HHS may consider representation of a
nominee’s knowledge, experience, and
expertise in the fields of health physics,
industrial hygiene, toxicology,
epidemiology, occupational medicine,
or the worker perspective in the nuclear
facilities spanning the operationally and
geographically diverse DOE and AWE
E:\FR\FM\02JYN1.SGM
02JYN1
lotter on DSK11XQN23PROD with NOTICES1
35292
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
facilities covered by the EEOICPA
programs; or familiarity, experience, or
history of participation with the
EEOICPA program. Any interested
person or organization may nominate
one or more individuals for
membership. Interested persons are also
invited and encouraged to submit
statements in support of nominees.
The ABRWH consists of not more
than 20 members appointed by the
President of the United States. As
required by 42 U.S.C. 7384o(a)(2), the
President makes appointments to the
ABRWH in consultation with
organizations with expertise on worker
health issues in order to ensure that the
membership of the ABRWH reflects a
balance of scientific, medical, and
worker perspectives. As required by 42
U.S.C. 7384o(a)(3), the President
designates a Chair for the ABRWH from
among its members. The authorizing
statutory provision under 42 U.S.C.
7384o and Section 4 of Executive Order
13179 do not include a limit for terms
of appointment for ABRWH members.
Nomination Process: Any interested
person or organization may nominate
one or more qualified individuals for
membership. If you would like to
nominate an individual or yourself for
appointment to the ABRWH, please
submit the following information:
• The nominee’s contact information
(name, title, business address, business
phone, fax number, and/or business
email address) and current employment
or position.
• A copy of the nominee’s resume or
curriculum vitae; category of
membership (e.g., scientific, medical,
and/or worker perspective) that the
nominee represents; a summary of the
background, experience, and
qualifications that addresses the
nominee’s suitability for the nominated
membership category identified above.
• Articles or other documents the
nominee has authored that indicate the
nominee’s knowledge, experience, and
expertise in the fields of health physics,
industrial hygiene, toxicology,
epidemiology, occupational medicine,
or the worker perspective in the nuclear
facilities covered by the EEOICPA
program; or familiarity, experience, or
history of participation with the
EEOICPA program. Nominations may be
submitted by the candidate him or
herself, or by the person/organization
recommending the candidate.
• At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services. Candidates
may submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
employed by an HHS agency (e.g., CDC,
NIH, FDA, etc.).
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–14204 Filed 7–1–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–0307]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Gonococcal
Isolate Surveillance Project (GISP)’’ to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 8, 2021 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Gonococcal Isolate Surveillance
Project—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Gonococcal Isolate Surveillance
Project (GISP) was created in 1986 to
monitor trends in antimicrobial
susceptibilities of Neisseria gonorrhoeae
strains in the United States. GISP
continues to be a collaboration between
different branches of the CDC’s Division
of STD Prevention, selected regional
laboratories, and selected state/local
public health departments and their
associated STD specialty care clinics in
the United States. National
organizations, local jurisdictions and
individuals use data collected in GISP
to understand, monitor, and prevent
further transmission of antibiotic
resistant strains of N. gonorrhoeae. Data
from GISP are used to establish a
scientific basis for the selection of
gonococcal therapies and to allow proactive changes to treatment guidelines
before widespread resistance and
failures of treatment occur. To increase
capacity to detect and monitor resistant
gonorrhea and to improve the specificity
of GISP, this revision is being submitted
to include collection of remnant nucleic
acid amplification test (NAAT)
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Pages 35291-35292]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14204]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory Board
on Radiation and Worker Health for the Energy Employees Occupational
Illness Compensation Program Act of 2000
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the Advisory Board on Radiation
and Worker Health (ABRWH) for the Energy Employees Occupational Illness
Compensation Program Act of 2000 (EEOICPA). The ABRWH consists of not
more than 20 members appointed by the President of the United States,
and shall reflect a balance of scientific, medical, and worker
perspectives. Nominations are being sought for individuals who have
expertise and qualifications necessary to contribute to the
accomplishments of the ABRWH's objectives. Nominees will be appointed
based on their demonstrated qualifications, professional experience,
and knowledge of issues the ABRWH may be asked to consider. Federal
employees will not be considered for membership.
DATES: Nominations for individuals to serve on the ABRWH must be
submitted (postmarked, if sending by mail; submitted electronically; or
received, if hand delivered) no later than August 2, 2021. Packages
received after this time will not be considered.
ADDRESSES: Nominations may be submitted, including attachments, by any
of the following methods below:
Electronically: Email: (recommended) to Nancy Adams,
[email protected] (specify in the email subject line, ``Advisory Board on
Radiation and Worker Health Nomination''); or
Mail: Express Delivery, hand delivery messenger, or
courier service: Submit one copy of all required documents to the
following address: Nancy Adams, ABRWH, Office of the Director, National
Institute of Occupational Safety and Health, Centers for Disease
Control and Prevention, 395 E Street SW, Suite 9200, Patriots Plaza,
Washington, DC 20201.
Follow-up communications with nominees may occur as necessary
throughout the process.
FOR FURTHER INFORMATION CONTACT: Nancy Adams, National Institute for
Occupational Safety and Health (NIOSH); Telephone: (540) 431-8024;
Email: [email protected] (Specify in the email subject line, ``Advisory
Board on Radiation and Worker Health Nomination'').
SUPPLEMENTARY INFORMATION: The Centers for Disease Control and
Prevention (CDC) invites interested parties to submit nominations for
individuals to serve on the ABRWH for the Energy Employees Occupational
Illness Compensation Program Act of 2000. The ABRWH was established
pursuant to Section 3624 of Public Law 106-398, and Section 4 of
Executive Order 13179, ``Providing Compensation to America's Nuclear
Weapons Workers,'' dated December 7, 2000. The ABRWH is governed by the
provisions of the Federal Advisory Committee Act, Public Law 92-463, as
amended (5 U.S.C. app. 2), which sets forth standards for the formation
and use of advisory committees. The statutory authority for the ABRWH
is codified at 42 U.S.C. 7384o. The ABRWH currently operates under
Executive Order 13889, dated September 27, 2019.
Section 4(b) of Executive Order 13179 establishes that the ABRWH
shall provide advice to the Secretary, HHS on (1) the development of
guidelines to assess the likelihood that an individual with cancer
sustained the cancer in the performance of duty at a Department of
Energy (DOE) or an Atomic Weapons Employer (AWE) facility, and methods
for arriving at and providing reasonable estimates of the radiation
doses received by individuals applying for assistance under this
program for whom there are inadequate records of radiation exposure;
(2) the scientific validity and quality of dose reconstruction efforts
performed for purposes of the compensation program; and (3) upon
request by the Secretary, HHS, whether there is a class of employees at
any DOE or AWE facility who were exposed to radiation but for whom it
is not feasible to estimate their radiation dose, and on whether there
is reasonable likelihood that such radiation dose may have endangered
the health of members of the class. More information on the ABRWH is
available at https://www.cdc.gov/niosh/ocas/ocasadv.html.
As required by 42 U.S.C. 7384o(a)(2), the President shall make
appointments to the Board in consultation with organizations with
expertise on worker health issues in order to ensure that the
membership of the Board reflects a balance of scientific, medical, and
worker perspectives. The U.S. Department of Health and Human Services
(HHS) policy stipulates that committee membership shall be made without
discrimination on the basis of race, color, sex, religion, ethnicity,
age, disability, gender, sexual orientation, gender identity, HIV
status, genetic information, cultural, religious, or socioeconomic
status. Minorities, women, and people with disability are encouraged to
submit their nomination. Nominees must be U.S. citizens, and cannot be
full-time employees of the U.S. government. Current participation on
Federal workgroups or prior experience serving on a Federal advisory
committee does not disqualify a candidate; however, HHS policy is to
avoid excessive individual service on advisory committees and multiple
committee memberships. ABRWH members are Special Government Employees
(SGEs), requiring the filing of financial disclosure reports, and they
serve with compensation and may receive reimbursement for travel
expenses for their attendance at ABRWH meetings, including per diem in
lieu of subsistence, as authorized by the Federal travel regulations.
The activities of the ABRWH may necessitate its members to obtain a
top-secret security clearance.
HHS may consider representation of a nominee's knowledge,
experience, and expertise in the fields of health physics, industrial
hygiene, toxicology, epidemiology, occupational medicine, or the worker
perspective in the nuclear facilities spanning the operationally and
geographically diverse DOE and AWE
[[Page 35292]]
facilities covered by the EEOICPA programs; or familiarity, experience,
or history of participation with the EEOICPA program. Any interested
person or organization may nominate one or more individuals for
membership. Interested persons are also invited and encouraged to
submit statements in support of nominees.
The ABRWH consists of not more than 20 members appointed by the
President of the United States. As required by 42 U.S.C. 7384o(a)(2),
the President makes appointments to the ABRWH in consultation with
organizations with expertise on worker health issues in order to ensure
that the membership of the ABRWH reflects a balance of scientific,
medical, and worker perspectives. As required by 42 U.S.C. 7384o(a)(3),
the President designates a Chair for the ABRWH from among its members.
The authorizing statutory provision under 42 U.S.C. 7384o and Section 4
of Executive Order 13179 do not include a limit for terms of
appointment for ABRWH members.
Nomination Process: Any interested person or organization may
nominate one or more qualified individuals for membership. If you would
like to nominate an individual or yourself for appointment to the
ABRWH, please submit the following information:
The nominee's contact information (name, title, business
address, business phone, fax number, and/or business email address) and
current employment or position.
A copy of the nominee's resume or curriculum vitae;
category of membership (e.g., scientific, medical, and/or worker
perspective) that the nominee represents; a summary of the background,
experience, and qualifications that addresses the nominee's suitability
for the nominated membership category identified above.
Articles or other documents the nominee has authored that
indicate the nominee's knowledge, experience, and expertise in the
fields of health physics, industrial hygiene, toxicology, epidemiology,
occupational medicine, or the worker perspective in the nuclear
facilities covered by the EEOICPA program; or familiarity, experience,
or history of participation with the EEOICPA program. Nominations may
be submitted by the candidate him or herself, or by the person/
organization recommending the candidate.
At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14204 Filed 7-1-21; 8:45 am]
BILLING CODE 4163-18-P
